Skip to main content

Warning notification:Warning

Unfortunately, you are using an outdated browser. Please, upgrade your browser to improve your experience with HSE. The list of supported browsers:

  1. Chrome
  2. Edge
  3. FireFox
  4. Opera
  5. Safari
HSE National Clinical Guideline

National Clinical Guideline - Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease


Topic: Cancer
Document Owner: National cancer control programme
National Group: Evidence and quality hub, nccp
Effective From: 13 May 2022
The purpose of this HSE National Clinical Guideline for the diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease.
National Clinical Guideline - Diagnosis, staging and treatment of patients with Gestational Trophoblastic Disease PDF, 2.12MB

This HSE National Clinical Guideline applies to all teenagers and adults that have a suspected diagnosis of Gestational Trophoblastic Disease (GTD). This guideline is intended for all health professionals involved in the diagnosis, staging and treatment of patients with GTD. Gestational trophoblastic disease (GTD) is a spectrum of diseases that can occur during or after pregnancy, each having a varying propensity for local invasion and metastasis.

Back to HSE National Policies, Procedures, Protocols, Guidelines and Clinical Guidelines